Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 ISIN · KYG1609T1022 HKEX Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2023-04-21 Annual Report
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
Annual Report 2022
Annual Report Classification · 100% confidence The document is titled '2022 Annual Report' for Broncus Holding Corporation and contains detailed sections typical of an annual report, including corporate information, financial highlights, chairman's statement, management discussion and analysis, directors and senior management, corporate governance report, environmental, social and governance report, independent auditor's report, consolidated financial statements, and notes to consolidated financial statements. The length is substantial (15,000 characters), and the content includes comprehensive financial data and business review for the fiscal year ended December 31, 2022. This matches the definition of an Annual Report (10-K). FY 2022
2023-04-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return regarding movements in securities for Broncus Holding Corporation, including authorized share capital, issued shares, share options, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The document does not contain financial statements or earnings data but focuses on share capital and share issuance movements. This type of filing corresponds to announcements about share capital changes and share issuance activities rather than a full financial report or earnings release. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive regulatory filing on share capital movements.
2023-04-11 English
(I) ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022&#x3b; AND (II) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND
Annual Report Classification · 100% confidence The document is an announcement of the audited consolidated annual results for the year ended December 31, 2022, including detailed financial highlights, business highlights, consolidated statements of profit or loss, comprehensive income, financial position, and notes to the consolidated financial statements. It contains extensive financial data and analysis for the full fiscal year, which is characteristic of an Annual Report. The document is not merely an announcement or a brief summary but includes comprehensive financial statements and notes, indicating it is the full report rather than a publication announcement or a regulatory filing. Therefore, the appropriate classification is Annual Report (10-K). FY 2022
2023-03-29 English
JOINT ANNOUNCEMENT - DISCLOSEABLE TRANSACTION INVESTMENT IN PARTNERSHIP FUND
Capital/Financing Update Classification · 95% confidence The document is a joint announcement by Broncus Holding Corporation and Venus Medtech regarding their investment in a partnership fund. It details the terms of the partnership agreement, capital contributions, and regulatory implications under the Hong Kong Listing Rules. The document is an announcement of a transaction (investment in a partnership fund) and includes disclosures about connected transactions and listing rule implications. It does not contain financial statements, audit opinions, or detailed financial results. It is not a full annual or interim report, nor a call transcript or earnings release. The document is a formal announcement of a capital/financing related transaction, specifically an investment and partnership agreement. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2023-03-29 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Broncus Holding Corporation regarding the completion of a cash transfer from Silicon Valley Bank and the company's view that this incident will not adversely impact its operations or financial position. The text is short (1949 characters), contains no financial statements or detailed financial data, and primarily provides an update on a specific event related to cash deposits and risk management. It does not present a full financial report, audit, earnings release, or other detailed filings. It is an announcement about a financial event but not a financing update or capital structure change per se. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-03-21 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from the Board of Directors of Broncus Holding Corporation stating the date of a board meeting to consider and approve the annual results for the year ended December 31, 2022. It does not contain the actual annual report or financial data but merely announces the upcoming meeting and the intention to publish the annual results. The document length is only 1444 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the 'MENU VS MEAL' rule, this is an announcement about the timing of a report publication, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2023-03-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.